Rivaroxaban-Amlodipin-Mepha 15 mg/5 mg
Rivaroxaban-Amlodipin-Mepha 15 mg/5 mg is a medicine authorised by Swissmedic under authorisation number 69789. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 September 2025 and the authorisation is limited until 25 September 2030. ATC code B01AF places the medicine in the group Antithrombotic agents.
| Authorisation number | 69789 |
|---|---|
| Name | Rivaroxaban-Amlodipin-Mepha 15 mg/5 mg |
| Full name | Rivaroxaban-Amlodipin-Mepha 15 mg/5 mg, Tabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B01AF |
| First authorisation | 26 September 2025 |
| Authorisation validity | 25 September 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rivaroxaban-Amlodipin-Mepha 15 mg/5 mg, Tabletten | B | 26 September 2025 |
| 2 | Rivaroxaban-Amlodipin-Mepha 15 mg/10 mg, Tabletten | B | 26 September 2025 |
| 3 | Rivaroxaban-Amlodipin-Mepha 20 mg/5 mg, Tabletten | B | 26 September 2025 |
| 4 | Rivaroxaban-Amlodipin-Mepha 20 mg/10 mg, Tabletten | B | 26 September 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | B01AF | 06.03.0. | B |
| 2 | 90 | Tablette(n) | B01AF | 06.03.0. | B |
| 3 | 30 | Tablette(n) | B01AF | 06.03.0. | B |
| 4 | 90 | Tablette(n) | B01AF | 06.03.0. | B |
| 5 | 30 | Tablette(n) | B01AF | 06.03.0. | B |
| 6 | 90 | Tablette(n) | B01AF | 06.03.0. | B |
| 7 | 30 | Tablette(n) | B01AF | 06.03.0. | B |
| 8 | 90 | Tablette(n) | B01AF | 06.03.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Rivaroxaban-Amlodipin-Mepha 15 mg/5 mg authorised in Switzerland?
Yes. Rivaroxaban-Amlodipin-Mepha 15 mg/5 mg is authorised by Swissmedic under authorisation number 69789, data as of 01 September 2026. The authorisation is limited until 25 September 2030.
Which dispensing category does Rivaroxaban-Amlodipin-Mepha 15 mg/5 mg have?
Rivaroxaban-Amlodipin-Mepha 15 mg/5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rivaroxaban-Amlodipin-Mepha 15 mg/5 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.